We report that decreased expression of miR-30c in tumor compared to adjacent tissue is sex-dependent in colorectal cancer (CRC) patients. High expression of miR-30c was associated with better survival in the whole cohort. When the cohort was split into male and female subcohorts, decreased miR-30c expression in tumor compared to adjacent tissue was observed only in males. Expression of miR-30c was decreased in CRC tumor tissue in male patients with nodes involvement compared to those without metastases in nodes and this difference was not observe in females. Next dependency of miR-30c expression on oestrogen receptor beta (ERbeta) mRNA levels in tumor was tested. In males with low expression of ERbeta, we observed a significant decrease in miR-30c levels in patients with nodes involvement compared to those without nodes involvement. This difference was not observed in males with high ERbeta mRNA levels and in females. Accordingly, males with low expression of ERbeta and high expression of miR-30c showed a better survival that those with low expression ERbeta and low expression of miR-30c. It is possible to conclude that whole cohort survival dependence on miR-30c is mostly generated by a subcohort of males with low expression of ERbeta mRNA in tumor tissue.

Department of Animal Physiology and Ethology Faculty of Natural Sciences Comenius University Bratislava Bratislava Slovak Republic

Zobrazit více v PubMed

ARNOLD M, RUTHERFORD MJ, BARDOT A, FERLAY J, ANDERSSON TM, MYKLEBUST TÅ, TERVONEN H, THURSFIELD V, RANSOM D, SHACK L, WOODS RR, TURNER D, LEONFELLNER S, RYAN S, SAINT-JACQUES N, DE P, McCLURE C, RAMANAKUMAR AV, STUART-PANKO H, ENGHOLM G, ET AL. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study. Lancet Oncol. 2019;20:1493–1505. doi: 10.1016/S1470-2045(19)30456-5. PubMed DOI PMC

BASKERVILLE S, BARTEL DP. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA. 2005;11:241–247. doi: 10.1261/rna.7240905. PubMed DOI PMC

BHAT-NAKSHATRI P, WANG G, COLLINS NR, THOMSON MJ, GEISTLINGER TR, CARROLL JS, BROWN M, HAMMOND S, SROUR EF, LIU Y, NAKSHATRI H. Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res. 2009;37:4850–4861. doi: 10.1093/nar/gkp500. PubMed DOI PMC

BRAY F, FERLAY J, SOERJOMATARAM I, SIEGEL RL, TORRE LA, JEMAL A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi: 10.3322/caac.21492. PubMed DOI

BUSK PK. A tool for design of primers for microRNA-specific quantitative RT-qPCR. BMC Bioinformatics. 2014;15:29. doi: 10.1186/1471-2105-15-29. PubMed DOI PMC

CAO JM, LI GZ, HAN M, XU HL, HUANG KM. MiR-30c-5p suppresses migration, invasion and epithelial to mesenchymal transition of gastric cancer via targeting MTA1. Biomed Pharmacother. 2017;93:554–560. doi: 10.1016/j.biopha.2017.06.084. PubMed DOI

CUI C, YANG W, SHI J, ZHOU Y, YANG J, CUI Q, ZHOU Y. Identification and analysis of human sex-biased microRNAs. Genomics Proteomics Bioinformatics. 2018;6:200–211. doi: 10.1016/j.gpb.2018.03.004. PubMed DOI PMC

DAVE VP, NGO TA, PERNESTIG AK, TILEVIK D, KANT K, NGUYEN T, WOLFF A, BANG DD. MicroRNA amplification and detection technologies: opportunities and challenges for point of care diagnostics. Lab Invest. 2019;99:452–469. doi: 10.1038/s41374-018-0143-3. PubMed DOI

DEROO BJ, BUENSUCESO AV. Minireview: Estrogen receptor-beta: mechanistic insights from recent studies. Mol Endocrinol. 2010;24:1703–1714. doi: 10.1210/me.2009-0288. PubMed DOI PMC

FUENTES N, SILVEYRA P. Estrogen receptor signaling mechanisms. Adv Protein Chem Struct Biol. 2019;116:135–170. doi: 10.1016/bs.apcsb.2019.01.001. PubMed DOI PMC

GRIFFITHS-JONES S. The microRNA registry. Nucleic Acids Res. 2004;J32:D109–D111. doi: 10.1093/nar/gkh023. Database issue. PubMed DOI PMC

GURTNER A, MANNI I, PIAGGIO G. NF-Y in cancer: Impact on cell transformation of a gene essential for proliferation. Biochim Biophys Acta Gene Regul Mech. 2017;1860:604–616. doi: 10.1016/j.bbagrm.2016.12.005. PubMed DOI

GUO L, ZHANG Q, MA X, WANG J, LIANG T. miRNA and mRNA expression analysis reveals potential sex-biased miRNA expression. Sci Rep. 2017;7:39812. doi: 10.1038/srep39812. PubMed DOI PMC

HAN W, CUI H, LIANG J, SU X. Role of MicroRNA-30c in cancer progression. J Cancer. 2020;11:2593–2601. doi: 10.7150/jca.38449. PubMed DOI PMC

HASÁKOVÁ K, BEZAKOVA J, VICIAN M, REIS R, ZEMAN M, HERICHOVA I. Gender-dependent expression of leading and passenger strand of miR-21 and miR-16 inhuman colorectal cancer and adjacent colonic tissues. Physiol Res. 2017;66(Suppl 4):S575–S582. doi: 10.33549/physiolres.933808. PubMed DOI

HASAKOVA K, REIS R, VICIAN M, ZEMAN M, HERICHOVA I. Expression of miR-34a-5pis up-regulated in human colorectal cancer and correlates with survival and clock gene PER2 expression. PLoS One. 2019;14:e0224396. doi: 10.1371/journal.pone.0224396. PubMed DOI PMC

HE YQ, SHENG JQ, LING XL, FU L, JIN P, YEN L, RAO J. Estradiol regulates miR-135b and mismatch repair gene expressions via estrogen receptor-β in colorectal cells. Exp Mol Med. 2012;44:723–732. doi: 10.3858/emm.2012.44.12.079. PubMed DOI PMC

HERICHOVA I, REIS R, HASAKOVA K, VICIAN M, ZEMAN M. Sex-dependent regulation of estrogen receptor beta in human colorectal cancer tissue and its relationship with clock genes and VEGF-A expression. Physiol Res. 2019;68(Suppl 3):S297–S305. doi: 10.33549/physiolres.934352. PubMed DOI

IRANI S, HUSSAIN MM. Role of microRNA-30c in lipid metabolism, adipogenesis, cardiac remodeling and cancer. Curr Opin Lipidol. 2015;26:139–146. doi: 10.1097/MOL.0000000000000162. PubMed DOI

JACOB H, STANISAVLJEVIC L, STORLI KE, HESTETUN KE, DAHL O, MYKLEBUST MP. Identification of a sixteen-microRNA signature as prognostic biomarker for stageII and III colon cancer. Oncotarget. 2017;8:87837–87847. doi: 10.18632/oncotarget.21237. PubMed DOI PMC

KONG X, XU X, YAN Y, GUO F, LI J, HU Y, ZHOU H, XUN Q. Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer. PLoS One. 2014;9:e90810. doi: 10.1371/journal.pone.0090810. PubMed DOI PMC

KOTTOROU AE, ANTONACOPOULOU AG, DIMITRAKOPOULOS FI, TSAMANDAS AC, SCOPA CD, PETSAS T, KALOFONOS HP. Altered expression of NFY-C and RORA in colorectal adenocarcinomas. Acta Histochem. 2012;114:553–561. doi: 10.1016/j.acthis.2011.10.005. PubMed DOI

LI Y, KOWDLEY KV. MicroRNAs in common human diseases. Genomics Proteomics Bioinformatics. 2012;10:246–253. doi: 10.1016/j.gpb.2012.07.005. PubMed DOI PMC

MAILLOT G, LACROIX-TRIKI M, PIERREDON S, GRATADOU L, SCHMIDT S, BÉNÈS V, ROCHÉ H, DALENC F, AUBOEUF D, MILLEVOI S, VAGNER S. Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth. Cancer Res. 2009;69:8332–8340. doi: 10.1158/0008-5472.CAN-09-2206. PubMed DOI

NAKAYAMA T, FUNAKOSHI-TAGO M, TAMURA H. Coffee reduces KRAS expression in Caco-2 human colon carcinoma cells via regulation of miRNAs. Oncol Lett. 2017;14:1109–1114. doi: 10.3892/ol.2017.6227. PubMed DOI PMC

OBER C, LOISEL DA, GILAD Y. Sex-specific genetic architecture of human disease. Nat Rev Genet. 2008;9:911–922. doi: 10.1038/nrg2415. PubMed DOI PMC

OSTENFELD MS, JENSEN SG, JEPPESEN DK, CHRISTENSEN LL, THORSEN SB, STENVANG J, HVAM ML, THOMSEN A, MOURITZEN P, RASMUSSEN MH, NIELSEN HJ, ØRNTOFT TF, ANDERSENCL miRNA profiling of circulating EpCAM(+) extracellular vesicles: promising biomarkers of colorectal cancer. J Extracell Vesicles. 2016;5:31488. doi: 10.3402/jev.v5.31488. PubMed DOI PMC

PIDÍKOVA P, REIS R, HERICHOVA I. miRNA clusters with down-regulated expression in human colorectal cancer and their regulation. Int J Mol Sci. 2020;21:4633. doi: 10.3390/ijms21134633. PubMed DOI PMC

SLACK FJ, CHINNAIYAN AM. The role of non-coding RNAs in oncology. Cell. 2019;179:1033–1055. doi: 10.1016/j.cell.2019.10.017. PubMed DOI PMC

STRUBBERG AM, MADISON BB. MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications. Dis Model Mech. 2017;10:197–214. doi: 10.1242/dmm.027441. PubMed DOI PMC

WANG Z, KATSAROS D, BIGLIA N, SHEN Y, LOO L, YU X, LIN H, FU Y, CHU WM, FEI P, NI Y, JIA W, DENG X, QIAN B, YU H. ERα upregulates the expression of long non-coding RNA LINC00472 which suppresses the phosphorylation of NF-κB in breast cancer. Breast Cancer Res Treat. 2019;175:353–368. doi: 10.1007/s10549-018-05108-5. PubMed DOI PMC

WILLIAMS C, EDVARDSSON K, LEWANDOWSKI SA, STRÖM A, GUSTAFSSON JA. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene. 2008;27:1019–1032. doi: 10.1038/sj.onc.1210712. PubMed DOI

WILLIAMS C, DILEO A, NIV Y, GUSTAFSSON JÅ. Estrogen receptor beta as target for colorectal cancer prevention. Cancer Lett. 2016;372:48–56. doi: 10.1016/j.canlet.2015.12.009. PubMed DOI PMC

YANG SJ, YANG SY, WANG DD, CHEN X, SHEN HY, ZHANG XH, ZHONG SL, TANG JH, ZHAO JH. The miR-30 family: Versatile players in breast cancer. Tumour Biol. 2017;39:1010428317692204. doi: 10.1177/1010428317692204. PubMed DOI

YE Y, YANG S, HAN Y, SUN J, XV L, WU L, WANG Y, MING L. Linc00472 suppresses proliferation and promotes apoptosis through elevating PDCD4 expression by sponging miR-196a in colorectal cancer. Aging. 2018;10:1523–1533. doi: 10.18632/aging.101488. PubMed DOI PMC

ZHAO DW, LI MM, HAN JP, WANG Y, JIANG LX, CHANG HL. MiR-30c exerts tumor suppressive functions in colorectal carcinoma by directly targeting BCL9. Eur Rev Med Pharmacol Sci. 2019;23:3335–3343. doi: 10.26355/eurrev_201904_17696. PubMed DOI

ZHANG Q, YU L, QIN D, HUANG R, JIANG X, ZOU C, TANG Q, CHEN Y, WANG G, WANG X, GAO X. Role of microRNA-30c targeting ADAM19 in colorectal cancer. PLoS One. 2015;10:e0120698. doi: 10.1371/journal.pone.0120698. PubMed DOI PMC

Genistein does not inhibit TGF-beta1-induced conversion of human dermal fibroblasts to myofibroblasts